PTHLH and neoplasm: Tumor-derived osteoclastogenic factors, such as interleukin 1 (IL-1), IL-6, parathyroid hormone-related protein (PTHrP), prostaglandin E2 (PEG2), CSF-1 and tumor necrosis factor-α (TNFα) drive an increase in bone resorption.